133
Participants
Start Date
October 14, 2021
Primary Completion Date
February 9, 2023
Study Completion Date
February 29, 2024
100 mg PRAX-944
Once daily oral treatment with titration
60 mg PRAX-944
Once daily oral treatment with titration
Placebo
Once daily oral treatment
Flexibly dosed 20 mg to 100 mg PRAX-944
Once daily oral treatment
Praxis Research Site, New York
Praxis Research Site, New York
Praxis Research Site, Philadelphia
Praxis Research Site, Rockville
Praxis Research Site, Alexandria
Praxis Research Site, Virginia Beach
Praxis Research Site, Jacksonville
Praxis Research Site, Gainesville
Praxis Research Site, West Palm Beach
Praxis Research Site, Boca Raton
Praxis Research Site, Tampa
Praxis Research Site, St. Petersburg
Praxis Research Site, Port Charlotte
Praxis Research Site, Birmingham
Praxis Research Site, Louisville
Praxis Research Site, Cincinnati
Praxis Research Site, Farmington Hills
Praxis Research Site, Milwaukee
Praxis Research Site, Golden Valley
Praxis Research Site, Chicago
Praxis Research Site, Kansas City
Praxis Research Site, Little Rock
Praxis Research Site, Houston
Praxis Research Site, Georgetown
Praxis Research Site, Round Rock
Praxis Research Site, Aurora
Praxis Research Site, Las Vegas
Praxis Research Site, Santa Monica
Praxis Research Site, Torrance
Praxis Research Site, San Diego
Praxis Research Site, Kirkland
Praxis Research Site, Spokane
Praxis Research Site, Boston
Praxis Research Site, Burlington
Praxis Research Site, Burlington
Praxis Research Site, Vancouver
Praxis Research Site, Halifax
Praxis Research Site, Toronto
Praxis Research Site, Montreal
Lead Sponsor
Praxis Precision Medicines
INDUSTRY